0 522

Cited 0 times in

The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane

Authors
 Dong Ki Lee  ;  Hyun Soo Kim  ;  Kyung-Sik Kim  ;  Woo Jung Lee  ;  Ho Keun Kim  ;  Young Hyun Won  ;  Young Ro Byun  ;  Moon Young Kim  ;  Soon Koo Baik  ;  Sang Ok Kwon 
Citation
 GASTROINTESTINAL ENDOSCOPY, Vol.61(2) : 296-301, 2005 
Journal Title
GASTROINTESTINAL ENDOSCOPY
ISSN
 0016-5107 
Issue Date
2005
MeSH
Animals ; Antineoplastic Agents, Phytogenic/administration & dosage* ; Bile Ducts*/pathology ; Drug Delivery Systems* ; Equipment Design ; Membranes, Artificial ; Paclitaxel/administration & dosage* ; Stents* ; Swine
Keywords
15729251
Abstract
BACKGROUND: Biliary metallic stents are covered with a membrane to prevent tumor ingrowth and to prolong patency. The only function of these stents is to promote biliary drainage; they have no antitumor effect.
METHODS: A metallic stent was developed that is covered with a paclitaxel-incorporated membrane. The metallic stents were coated with one of 3 concentrations of paclitaxel (0, 10, and 20 % wt/v) and polyurethane. A stent with each concentration was surgically inserted in the bile duct of two pigs. Four weeks after insertion, the segment of bile duct containing the stent was examined histologically. To determine the efficacy of the drug release, stents were placed in phosphate buffered saline solution for 6 weeks, and the amount of paclitaxel released was measured by high-performance liquid chromatography.
RESULTS: The histologic changes in the pig biliary epithelium were acceptable with respect to safety and included inflammatory cell infiltration and fibrous reactions. The changes corresponded to the amount of paclitaxel incorporated within the stent in contact with the bile duct. Epithelial denudation, mucin hypersecretion, and epithelial metaplasia were noted in the bile ducts that were in contact with stents containing 20 % wt/v paclitaxel. Transmural necrosis and perforation were not observed in any animal. In the in vitro experiment, the amounts of paclitaxel released over 1 week and over 6 weeks were similar, regardless of the concentration of paclitaxel incorporated in the stent. The stent with 10% (wt/v) paclitaxel in the covering membrane was found to be better than that with 20 % (wt/v) with respect to histologic changes and the effectiveness of drug release.
CONCLUSIONS: A paclitaxel-incorporated metallic stent could serve as a basis for the development of a new and safe treatment modality for malignant biliary obstruction. Clinical trials of this stent with other adjuvant therapy are warranted.
Full Text
http://www.sciencedirect.com/science/article/pii/S0016510704025702
DOI
OAK-2005-04179
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Kyung Sik(김경식) ORCID logo https://orcid.org/0000-0001-9498-284X
Kim, Hogeun(김호근)
Lee, Dong Ki(이동기) ORCID logo https://orcid.org/0000-0002-0048-9112
Lee, Woo Jung(이우정) ORCID logo https://orcid.org/0000-0001-9273-261X
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/150574
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links